SCHEMBL20157720

SCHEMBL20157720

Cc1ccc(C(=O)c2cc(Cl)c(C(Br)Br)cc2Br)cc1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 5/20 0.44
ALDH1A1 P00352 3/20 0.42
LMNA P02545 2/20 0.42
HTT P42858 4/20 0.41
NPC1 O15118 2/20 0.41
MAPK1 P28482 1/20 0.41
RXRA P19793 1/20 0.41
AKR1C3 P42330 1/20 0.40
L3MBTL1 Q9Y468 3/20 0.39
RAB9A P51151 1/20 0.39
GAA P10253 1/20 0.39
CNR1 P21554 1/20 0.38
CNR2 P34972 1/20 0.38
SRD5A2 P31213 2/20 0.38
CES2 O00748 1/20 0.37
CES1 P23141 1/20 0.37
NR4A1 P22736 1/20 0.36
KDM5A P29375 1/20 0.36
SMN1; SMN2 Q16637 1/20 0.36
KMT2A Q03164 2/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20157718 0.86 MDM2 (0.38) MAPTALDH1A1LMNAHTTRXRA
SCHEMBL21362627 0.83 MAPT (0.44) MAPTALDH1A1LMNAHTTNPC1
SCHEMBL20157705 0.82 MAPT (0.49) MAPTALDH1A1LMNAHTTNPC1
SCHEMBL20157944 0.81 MAPT (0.46) MAPTALDH1A1LMNAHTTNPC1
SCHEMBL20157492 0.79 MAPT (0.57) MAPTALDH1A1LMNAHTTNPC1
SCHEMBL20157995 0.77 MAPT (0.44) MAPTALDH1A1LMNAHTTNPC1
SCHEMBL20157505 0.74 RXRA (0.38) MAPTALDH1A1LMNAHTTNPC1
SCHEMBL20157430 0.73 MAPT (0.60) MAPTALDH1A1LMNAHTTNPC1
SCHEMBL20157997 0.72 MAPT (0.40) MAPTALDH1A1LMNAHTTNPC1
SCHEMBL20157979 0.71 MAPT (0.43) MAPTALDH1A1LMNAHTTNPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3539960-A1 NITROGENOUS MACROCYCLIC COMPOUND, PREPARATION METHOD THEREFOR, PHARMACEUTICAL COMPOSITION AND APPLICATION THEREOF Luoxin Pharmaceutical (Shanghai) Co., Ltd. (CN) 2019-09-18 EP disclosed
WO-2018086605-A1 NITROGENOUS MACROCYCLIC COMPOUND, PREPARATION METHOD THEREFOR, PHARMACEUTICAL COMPOSITION AND APPLICATION THEREOF 山东罗欣药业集团股份有限公司 2018-05-17 WO disclosed